Price T Rowe Associates Inc Biomarin Pharmaceutical Inc Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,102,313 shares of BMRN stock, worth $90.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,102,313

Previous 1,605,983 31.36%

Holding current value

$90.8 Million

Previous $155 Million 37.83%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $42.2 Million - $49.9 Million	-503,670 Reduced 31.36%	1,102,313 $96.3 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $30.6 Million - $39.5 Million	401,152 Added 33.3%	1,605,983 $155 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $7.39 Million - $8.21 Million	-86,847 Reduced 6.72%	1,204,831 $107 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $205,344 - $237,610	-2,369 Reduced 0.18%	1,291,678 $112 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $32.1 Million - $42.9 Million	366,211 Added 39.47%	1,294,047 $126 Million

Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $25.6 Million - $34.3 Million	316,129 Added 51.68%	927,836 $96 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $7.14 Million - $8.42 Million	86,888 Added 16.56%	611,707 $51.9 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $76.1 Million - $92.5 Million	-1,064,526 Reduced 66.98%	524,819 $43.5 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $27.5 Million - $34.3 Million	370,312 Added 30.38%	1,589,345 $123 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $297,351 - $379,234	4,146 Added 0.34%	1,219,033 $108 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $33.3 Million - $38.1 Million	-445,429 Reduced 26.83%	1,214,887 $93.9 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $18.9 Million - $21.2 Million	-250,194 Reduced 13.1%	1,660,316 $139 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $11.5 Million - $14 Million	-154,072 Reduced 7.46%	1,910,510 $144 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $150 Million - $186 Million	2,064,582 New	2,064,582 $181 Million

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Biomarin Pharmaceutical Inc Transaction History